Product Information
LORAZEPAM 0.5 MG TABLET is a generic product labeled by Major Pharmaceuticals, priced at $0.0334 per EA under NDC 00904600761. Its NADAC has been published 530 times since Jun 29, 2016.
FDA first approved this application on Jul 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Major PharmaceuticalsNDC
00904600761
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LORAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA078203FDA Approved
7/30/2007
TE Code
AB
On Market Since
10/9/2009
Pharmacological Classes
Price Statistics
The NADAC for LORAZEPAM 0.5 MG TABLET has been published 530 times since Jun 29, 2016, and over the history we have for it it has risen 66.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0334 per EA |
|---|---|
| All-time high | $0.0464 (Mar 13, 2024) |
| All-time low | $0.0200 (Jun 29, 2016) |
| 52-week high | $0.0430 |
| 52-week low | $0.0328 |
| Median price | $0.0352 |
| Average price | $0.0338 |
| Largest weekly change | +30.1% (Dec 23, 2020) |
| Weeks tracked | 530 |
| Tracking since | Jun 29, 2016 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LORAZEPAM 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Major Pharmaceuticals, is $0.0334 per EA (NDC 00904600761), effective Aug 19, 2026.
How has the price of LORAZEPAM 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has risen 66.4%. It has been tracked across 530 weekly CMS publications since Jun 29, 2016.
What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?
Since Jun 29, 2016, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0200 (Jun 29, 2016) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0352 per EA.
Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 39% below LORAZEPAM 0.5 MG TABLET.
Who manufactures LORAZEPAM 0.5 MG TABLET?
LORAZEPAM 0.5 MG TABLET (NDC 00904600761) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.